Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients.
BMC Psychiatry January 6, 2020 Sarah Frances, Frances Shawyer, Bruno Cayoun et al.
A transdiagnostic treatment called mindfulness-integrated cognitive behavior therapy (MiCBT) combines cognitive behavioral techniques with mindfulness meditation from the Vipassana tradition, focusing on body scanning to develop interoceptive awareness and equanimity. This randomized controlled trial will test whether group MiCBT reduces depression and anxiety symptoms in 120 adults with high psychological distress (K10 score of 20 or more) recruited from primary care. Participants will be assigned to an 8-week MiCBT program or a wait-list control group, with outcomes measured using the DASS-21 and K10. The study aims to determine if MiCBT offers a comprehensive therapeutic system applicable across diagnostic groups.